Reuters logo
BRIEF-Hunan Er-kang Pharmaceutical sees Q1 net profit up 18-38 pct
April 7, 2017 / 9:52 AM / 6 months ago

BRIEF-Hunan Er-kang Pharmaceutical sees Q1 net profit up 18-38 pct

April 7 (Reuters) - Hunan Er-kang Pharmaceutical Co Ltd

* Says it sees q1 net profit up 18-38 percent y/y from 168 million yuan ($24.37 million) a year earlier

Source text in Chinese: bit.ly/2oQ3GWT

Further company coverage: ($1 = 6.8950 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below